ECOLE NORMALE SUPERIEURE DE LYON Patent applications |
Patent application number | Title | Published |
20160040353 | METHOD FOR DEPOSITING A PHOTOCATALYTIC COATING AND RELATED COATINGS, TEXTILE MATERIALS AND USE IN PHOTOCATALYSIS - A method for depositing a photocatalytic coating on a support, the method having the steps: a) providing an aqueous and/or alcoholic suspension of nanoparticles of a semiconducting material, b) providing a sol in an aqueous and/or alcoholic solution of a hydrolyzed organosilane, c) mixing the suspension and the sol and proceeding with deposition of the obtained mixture on the support to be covered, d) performing a drying operation, e) and optionally producing an illumination of the obtained coating after drying at one wavelength at least causing activation of the semiconducting material, so as to remove at least 3% of the organic groups initially present in the coating and bound to the silicon atoms through a Si—C bond; as well as coatings with photocatalytic properties, materials, notably textiles, covered with such a coating and the use of such coatings and materials for photocatalysis. | 02-11-2016 |
20140336373 | NOVEL COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES - The present invention concerns complexing agents of formula (I) in which a, b, c, chrom | 11-13-2014 |
20140186364 | INHIBITION OF THE NT-3:TRKC BOUND AND ITS APPLICATION TO THE TREATMENT OF CANCER SUCH AS NEUROBLASTOMA - The subject matter of the present disclosure relates to an in vitro method for the screening of anti-cancer compounds based on the capacity for these compounds to interact with neurotrophin 3 (NT-3 or NT3), to the extracellular domain or TrkC receptor and/or to inhibit the dimerization of the intracellular domain of the TrkC receptor expressed in tumor cells, particularly in neuroblastoma. The disclosure also relates to a method for predicting the presence of metastatic cancer or a bad prognosis cancer, or for determining the efficiency of an anti-cancer treatment based on the measuring of the expression level of neurotrophin 3. The disclosure further comprises kits and compounds as a medicament for the treatment of neuroblastoma or cancer overexpressing neurotrophin 3 by the tumor cells. | 07-03-2014 |
20140069865 | METHOD FOR HIGH-THROUGHPUT SCREENING OF DROPS BY OSMOTIC EXCHANGE AND DENSITY VARIATION - This method comprises bringing drops to be separated into contact with an interface ( | 03-13-2014 |
20130132546 | TOOL FOR MANAGING RESOURCES AND COMPUTER INFRASTRUCTURES AND NETWORKS - A tool for aiding management of a communicating physical device includes: a device controller operating the physical device using operating parameters; a data storage interlinking an identifier from the physical device and dated values of attributes and a list of control functions capable of modifying some of the operating parameters; an interpreter adapted for receiving a device identifier datum and a time horizon parameter at the same time and for responding thereto by establishing a series of respective events using the information from the data storage, related to the time horizon, each event interlinking a date, one or more identifiers of control functions, and parameters for these functions, established in accordance with a dated attribute value; and a sequencer arranged to call the interpreter and carry out chronologically the calls of the functions of each event of the series as returned by the interpreter. | 05-23-2013 |
20130123508 | NOVEL NONLINEAR CHROMOPHORES ESPECIALLY SUITED FOR USE IN ELECTRO-OPTICAL MODULATION - The present invention relates to heptamethine hemicyanine chromophores of formula (I): where R | 05-16-2013 |
20130060550 | METHOD OF TOXICOLOGICAL EVALUATION, METHOD OF TOXICOLOGICAL SCREENING AND ASSOCIATED SYSTEM - The present invention relates to a method of toxicological evaluation of a candidate substance on at least one tissue or organ, characterized in that it comprises the steps of: (a) obtaining a bioartificial tissue or organ by simulation or modelling of the metabolic activity of said tissue or organ by at least one bioreactor; (b) exposure of said bioartificial tissue or organ to said substance; (c) observation of the metabolic response of the bioartificial tissue or organ and acquisition without a priori of an associated multidimensional data set; (d) identification by means of a method of multivariate statistical analysis of the components of the multidimensional data set which are quantitatively correlated with predetermined variables; (e) generation of a predictive model on the basis of the components of the data set that are actually retained; (f) testing of the predictive nature of said model by at least one statistical method of estimating reliability; (g) identification of the metabolic response of the bioartificial tissue or organ in the form of biomarkers associated with the components of the data set that are adopted for the model. The present invention also relates to a method of toxicological screening and to a system for this purpose. | 03-07-2013 |
20120019907 | HIGH-RESOLUTION SURFACE PLASMON MICROSCOPE THAT INCLUDES A HETERODYNE FIBER INTERFEROMETER - The present invention relates to a high-resolution surface plasmon microscope including a heterodyne interferometer ( | 01-26-2012 |
20120015364 | METHOD FOR THE SELECTION OF ENDOTHELIAL CELLS DEATH INDUCERS VIA NETRIN-1 AND ITS APPLICATIONS - The present invention relates to an in vitro method for selecting a compound capable to induce the death of endothelial cells, preferably endothelial cells from vessels or neovessels. The invention further comprises the use of netrin-1 function inhibitors as compounds capable to induce the death of endothelial cells, preferably endothelial cells from vessels or neovessels of tumor expressing netrin-1. Finally, the invention relates to a kit for the selection of a compound capable to induce the death of endothelial cells. | 01-19-2012 |
20110229485 | INHIBITION OF THE NT-3:TRKC BOUND AND ITS APPLICATION TO THE TREATMENT OF CANCER SUCH AS NEUROBLASTOMA - The subject matter of the present disclosure relates to an in vitro method for the screening of anti-cancer compounds based on the capacity for these compounds to interact with neurotrophin 3 (NT-3 or NT3), to the extracellular domain, or TrkC receptor and/or to inhibit the dimerization of the intracellular domain of the TrkC receptor expressed in tumor cells, particularly in neuroblastoma. The disclosure also relates to a method for predicting the presence of metastatic cancer or a bad prognosis cancer, or for determining the efficiency of an anti-cancer treatment based on the measuring of the expression level of neurotrophin 3. The disclosure further comprises kits and compounds as a medicament for the treatment of neuroblastoma or cancer overexpressing neurotrophin 3 by the tumor cells. | 09-22-2011 |
20110004344 | MIXER, AND DEVICE AND METHOD FOR MONITORING OR CONTROLLING SAID MIXER - The invention relates to a mixer that includes:—at least one instrumented particle ( | 01-06-2011 |
20100213356 | Passive Optical Limiter Having Nonlinear Material - The invention relates to a passive optical limiter having a nonlinear material capable of switching in a predetermined optical band from a transparent state to an opaque state as a function of the power of an incident laser beam. The nonlinear material is an organic dye which comprises molecules derived from 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene into which a nitrogen atom is inserted at the meso position, referred to as aza-bodipy molecules, and which have conjugated π chains functionalized so as to exhibit absorption for two photons around an incident beam wavelength lying between 1.45 μm and 1.6 μm. | 08-26-2010 |